Linkage and association on 8p21.2-p21.1 in schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 2, 2011, Pages 188-197

  Fallin, M Daniele ^a   Lasseter, Virginia K ^b   Liu, Yaping ^b   Avramopoulos, Dimitrios ^b   McGrath, John ^b   Wolyniec, Paula S ^b   Nestadt, Gerald ^b   Liang, Kung Yee ^a   Chen, Pei Lung ^b   Valle, David ^b   Pulver, Ann E ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Association; Chromosome 8; DPYSL2; Schizophrenia

Indexed keywords

ARTICLE; CHROMOSOME 8P; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOMICS; GENOTYPE; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GENETIC LINKAGE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; META-ANALYSIS AS TOPIC; NERVE TISSUE PROTEINS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 79551710080     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31154     Document Type: Article

References (81)

1. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. 2002. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30(1): 97-101.
2. Aleman A, Kahn RS, Selten JP. 2003. Sex differences in the risk of schizophrenia: Evidence from meta-analysis. Arch Gen Psychiatry 60(6): 565-571.
3. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40(7): 827-834.
4. Arimura N, Menager C, Fukata Y, Kaibuchi K. 2004. Role of CRMP-2 in neuronal polarity. J Neurobiol 58(1): 34-47.
5. Badner JA, Gershon ES. 2002. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7(4): 405-411.
6. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2): 263-265.
7. Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. 2006. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics 6(11): 3414-3425.
8. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, et al. 1998. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20(1): 70-73.
9. Boyles AL, Scott WK, Martin ER, Schmidt S, Li YJ, Ashley-Koch A, Bass MP, Schmidt M, Pericak-Vance MA, Speer MC, et al. 2005. Linkage disequilibrium inflates type I error rates in multipoint linkage analysis when parental genotypes are missing. Hum Hered 59(4): 220-227.
10. Brzustowicz LM, Honer WG, Chow EW, Little D, Hogan J, Hodgkinson K, Bassett AS. 1999. Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet 65(4): 1096-1103.
11. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, et al. 1999. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychiatry 56(2): 162-168.
12. Charrier E, Reibel S, Rogemond V, Aguera M, Thomasset N, Honnorat J. 2003. Collapsin response mediator proteins (CRMPs): Involvement in nervous system development and adult neurodegenerative disorders. Mol Neurobiol 28(1): 51-64.
13. Chen P-L, Avramopoulos D, Lasseter VK, McGrath JA, Fallin MD, Liang K-Y, Nestadt G, Feng N, Steel G, Cutting AS, et al. 2009. Fine mapping on chromosome 10q22-q23 implicates neuregulin 3 (NRG3) in schizophrenia. Am J Hum Genet 84(1): 21-34.
14. Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP. 2007. Nociceptin/orphanin FQ peptide receptors: Pharmacology and clinical implications. Curr Drug Targets 8(1): 117-135.
15. Clark DA, Arranz MJ, Mata I, Lopez-Ilundain J, Perez-Nievas F, Kerwin RW. 2005. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population. Biol Psychiatry 58(6): 435-439.
16. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW, Wellman N, Loftus J, Nanthakumar B, Razi K, et al. 2002. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry 159(5): 803-812.
17. Duan JB, Sanders AR, Martinez M, He D, Li J, Burrell G, Buccola NG, Mowry BJ, Freedman R, Amin F, et al. 2007. Linkage Disequilibrium Mapping for Schizophrenia Susceptibility Genes on 8p23.3-p12 in a large European Ancestry Sample. San Diego, CA: American Society of Human genetics meeting.
18. Edgar PF, Douglas JE, Cooper GJ, Dean B, Kydd R, Faull RL. 2000. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry 5(1): 85-90.
19. Elia J, Capasso M, Zaheer Z, Lantieri F, Ambrosini P, Berrettini W, Devoto M, Hakonarson H. 2009. Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: Suggestive association signals in ADRA1A. Psychiatr Genet 19(3): 134-141.
20. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, et al. 2005. Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77(6): 918-936.
21. Falush D, Stephens M, Pritchard JK. 2003. Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics 164(4): 1567-1587.
22. Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, Lee C, Shia J, Markowitz A, Figer A, Friedman E, et al. 2002. The founder mutation MSH2*1906G->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 71(6): 1395-1412.
23. Fukata Y, Itoh TJ, Kimura T, Menager C, Nishimura T, Shiromizu T, Watanabe H, Inagaki N, Iwamatsu A, Hotani H, et al. 2002. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol 4(8): 583-591.
24. Garcia-Dominguez M, Poquet C, Garel S, Charnay P. 2003. Ebf gene function is required for coupling neuronal differentiation and cell cycle exit. Development 130(24): 6013-6025.
25. Gogos JA, Gerber DJ. 2006. Schizophrenia susceptibility genes: Emergence of positional candidates and future directions. Trends Pharmacol Sci 27(4): 226-233.
26. Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM. 1995. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376(6540): 509-514.
27. Gurling HM, Critchley H, Datta SR, McQuillin A, Blaveri E, Thirumalai S, Pimm J, Krasucki R, Kalsi G, Quested D, et al. 2006. Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. Arch Gen Psychiatry 63(8): 844-854.
28. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, et al. 2001. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23. 3-24 and 20q12.1-11.23. Am J Hum Genet 68(3): 661-673.
29. Hennekens CH. 2007. Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. J Clin Psychiatry 68 (Suppl 4): 4-7.
30. Holmans P, Riley B, Pulver A, Owen M, Wildenauer V, Gejman P, Mowry B, Laurent C, Kendler K, Nestadt G, et al. 2009. Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms. Mol Psychiatry 14(8): 786-795.
31. Hong LE, Wonodi I, Avila MT, Buchanan RW, McMahon RP, Mitchell BD, Stine OC, Carpenter WT, Jr., Thaker GK. 2005. Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia. Am J Med Genet Part B Neuropsychiatr Genet 136B(1): 8-11.
32. Horvath S, Xu X, Laird NM. 2001. The family based association test method: Strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9(4): 301-306.
33. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. 2004. Family-based tests for associating haplotypes with general phenotype data: Application to asthma genetics. Genet Epidemiol 26(1): 61-69.
34. Iwazaki T, McGregor IS, Matsumoto I. 2007. Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization. Proteomics 7(7): 1131-1139.
35. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, Yolken RH. 2000. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 5(2): 142-149.
36. Kamiya A, Tan PL, Kubo K, Engelhard C, Ishizuka K, Kubo A, Tsukita S, Pulver AE, Nakajima K, Cascella NG, et al. 2008. Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BB S4: A candidate for psychiatric illnesses. Arch Gen Psychiatry 65(9): 996-1006.
37. Karayiorgou M, Gogos JA. 2006. Schizophrenia genetics: Uncovering positional candidate genes. Eur J Hum Genet 14(5): 512-519.
38. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD, Meyer J, Zambuto CT, Schmitt K, Matise TC, et al. 1998. NIMH genetics initiative millenium schizophrenia consortium: Linkage analysis of African-American pedigrees. Am J Med Genet 81(4): 282-289.
39. Kawano Y, Yoshimura T, Tsuboi D, Kawabata S, Kaneko-Kawano T, Shirataki H, Takenawa T, Kaibuchi K. 2005. CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1 complex and axon formation. Mol Cell Biol 25(22): 9920-9935.
40. Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, Shinkwin R, Easter SM, Webb BT, Zhang J, et al. 1996. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 153(12): 1534-1540.
41. Kirov G, Zaharieva I, Georgieva L, Moskvina V, Nikolov I, Cichon S, Hillmer A, Toncheva D, Owen MJ, O'Donovan MC. 2009. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry 14(8): 796-803.
42. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. 1996. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 58(6): 1347-1363.
43. Lasky-Su J, Neale BM, Franke B, Anney RJ, Zhou K, Maller JB, Vasquez AA, Chen W, Asherson P, Buitelaar J, et al. 2008. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet Part B Neuropsychiatr Genet 147B(8): 1345-1354.
44. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR. 2006. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci USA 103(17): 6747-6752.
45. Leung A, Chue P. 2000. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 401:3-38.
46. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, et al. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73(1): 34-48.
47. Liu CM, Hwu HG, Fann CS, Lin CY, Liu YL, Ou-Yang WC, Lee SF. 2005. Linkage evidence of schizophrenia to loci near neuregulin 1 gene on chromosome 8p21 in Taiwanese families. Am J Med Genet Part B Neuropsychiatr Genet 134B(1): 79-83.
48. Liu Y, McGaughey DM, Zhang L, Chen P, Avramopoulos D, Lasseter V, Fallin D, McGrath J, Wolyniec P, Nestadt G, et al. 2008. Assessing the Biological Relevance of Sequence Variants in and Around DPYSL2, a Candidate Schizophrenia (SZ) Susceptibility Gene on 8p21. Philadelphia, PA: American Society of Human Genetics.
49. McClellan JM, Susser E, King MC. 2007. Schizophrenia: A common disease caused by multiple rare alleles. Br J Psychiatry 190:194-199.
50. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. 2004. A systematic review of the incidence of schizophrenia: The distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2:13.
51. Meis S. 2003. Nociceptin/orphanin FQ: Actions within the brain. Neuroscientist 9(2): 158-168.
52. Nakata K, Ujike H, Sakai A, Takaki M, Imamura T, Tanaka Y, Kuroda S. 2003. The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia. Biol Psychiatry 53(7): 571-576.
53. Ng M, Levinson D, Faraone S, Suarez B, DeLisi L, Arinami T, Riley B, Paunio T, Pulver A, Irmansyah, et al. 2009. Meta-analysis of 32 genomewide linkage studies of schizophrenia. Mol Psychiatry 14(8): 774-785.
54. Nourian Z, Mulvany MJ, Nielsen KB, Pickering DS, Kristensen T. 2008. The antagonistic effect of antipsychotic drugs on a HEK293 cell line stably expressing human alpha1A1-adrenoceptors. Eur J Pharmacol 596(1-3): 32-40.
55. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, et al. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40(9): 1053-1055.
56. Owen MJ, Craddock N, O'Donovan MC. 2010. Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Arch Gen Psychiatry 67(7): 667-673.
57. Owen MJ, Williams NM, O'Donovan MC. 2004. The molecular genetics of schizophrenia: New findings promise new insights. Mol Psychiatry 9(1): 14-27.
58. Paulson L, Martin P, Nilsson CL, Ljung E, Westman-Brinkmalm A, Blennow K, Davidsson P. 2004. Comparative proteome analysis of thalamus in MK-801-treated rats. Proteomics 4(3): 819-825.
59. Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data. Genetics 155(2): 945-959.
60. Pulver AE, Bale SJ. 1989. Availability of schizophrenic patients and their families for genetic linkage studies: Findings from the Maryland epidemiology sample. Genet Epidemiol 6(6): 671-680.
61. Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL, Kimberland M, Babb R, Vourlis S, Chen H, et al. 1995. Schizophrenia: A genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 60(3): 252-260.
62. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3): 559-575.
63. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256): 748-752.
64. Rice DP. 1999. The economic impact of schizophrenia. J Clin Psychiatry 60 (Suppl 1): 4-6 (discussion 28-30).
65. Riley B, Kendler KS. 2006. Molecular genetic studies of schizophrenia. Eur J Hum Genet 14(6): 669-680.
66. Rogemond V, Auger C, Giraudon P, Becchi M, Auvergnon N, Belin MF, Honnorat J, Moradi-Ameli M. 2008. Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition. J Biol Chem 283(21): 14751-14761.
67. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, et al. 2007. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316(5829): 1331-1336.
68. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, et al. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460(7256): 753-757.
69. Shifman S, Johannesson M, Bronstein M, Chen SX, Collier DA, Craddock NJ, Kendler KS, Li T, O'Donovan M, O'Neill FA, et al. 2008. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 4(2): e28.
70. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460(7256): 744-747.
71. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C, et al. 2003. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 72(1): 83-87.
72. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71(4): 4.
73. Straub RE, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, O'Neill FA, et al. 2002. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry 7(6): 542-559.
74. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, Hou C, Buccola NG, Hale N, Weilbaecher AN, Nertney DA, et al. 2006. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: Suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 78(2): 315-333.
75. Tabares-Seisdedos R, Rubenstein JL. 2009. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: Implications for schizophrenia, autism and cancer. Mol Psychiatry 14(6): 563-589.
76. Tan W, Wang Y, Gold B, Chen J, Dean M, Harrison PJ, Weinberger DR, Law AJ. 2007. Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem 282(33): 24343-24351.
77. Tosato S, Dazzan P, Collier D. 2005. Association between the neuregulin 1 gene and schizophrenia: A systematic review. Schizophr Bull 31(3): 613-617.
78. Ujike H, Sakai A, Nakata K, Tanaka Y, Kodaka T, Okahisa Y, Harano M, Inada T, Yamada M, Komiyama T, et al. 2006. Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis. Ann N Y Acad Sci 1074:90-96.
79. Wolyniec PS, Pulver AE, McGrath JA, Tam D. 1992. Schizophrenia: Gender and familial risk. J Psychiatr Res 26(1): 17-27.
80. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K. 2005. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120(1): 137-149.
81. Zhao X, Tang R, Xiao Z, Shi Y, Feng G, Gu N, Shi J, Xing Y, Yan L, Sang H, et al. 2006. An investigation of the dihydropyrimidinase-like 2 (DPYSL2) gene in schizophrenia: Genetic association study and expression analysis. Int J Neuropsychopharmacol 9(6): 705-712.